Successful Percutaneous Treatment of an Arteriovenous Malformation of the Toe

Kirkpatrick, Daniel; Frenette, Aaron; Hasham, Hasnain; Custer, Brandon; Lemons, Steven; Collins, Zachary; Alli, Adam

doi:10.1016/j.avsg.2019.11.034

Cited by 1 publication

(1 citation statement)

References 16 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…STS is an effective option for the treatment of AVM, as demonstrated by eventual complete resolution in the 26 patients in our study who underwent UGFS as monotherapy. Other studies treating AVMs with STS have had similar results [13,14].…”

Section: Discussionmentioning

confidence: 58%

Peripheral Arteriovenous Malformations and Their Response to Treatment Modalities: A Single Surgeon’s Experience at Tertiary Care Hospitals

Rashid

Hussain

Malik

et al. 2021

Preprint

View full text Add to dashboard Cite

Background Peripheral arteriovenous malformations (AVMs) are congenital defects resulting in abnormal connections between veins and arteries. We investigated a group of patients with peripheral AVMs to determine whether there were any gender differences in disease presentation and the response of AVMs to various modalities of treatment. Methodology The patients in this cross-sectional study were divided into two groups based on gender and their demographic data, clinical presentation at the time of diagnosis and response to treatment was assessed. Both surgical and nonsurgical treatment options were used. Nonsurgical options employed in the study included immunotherapy, embolotherapy and ultrasound-guided foam sclerotherapy (UGFS) Results Out of 43 patients, 74.4% were females with a male to female ratio of 1:3. The mean age at presentation in males was 27 years and 17 years in females. 60% of the male patients presented with high-flow AVMs while 81% of the female patients presented with low-flow lesions instead. Half of the AVMs in males were on the trunk whereas, in females, 93.9% were on the extremities. UGFS alone was used in 95.3% of patients while 32.5% of patients underwent UGFS followed by surgical excision. One patient was treated with sirolimus. In 4.6% of cases, embolization followed by surgical excision was performed. Recurrence was recorded in 20.9% of cases. Conclusions The clinical presentation of AVMs is notably different among the two genders. Sclerotherapy and embolotherapy proved to be effective treatment options. Larger studies, however, are needed to substantiate these claims. Keywords arteriovenous malformations, vascular malformations, sclerotherapy, embolotherapy, sirolimus

show abstract

Section: Discussionmentioning

confidence: 58%